Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025)
Neurogene's (NGNE) quarterly Asset Utilization Ratio came in at 0.0 in Q2 2025, down 38.76% YoY from 0.0 in Q2 2024, and down 18.41% on a QoQ basis from 0.0 in Q4 2024.
Analysis
Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025) Analysis & Trends
Neurogene (NGNE) has 4 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q2 2025.
- Quarterly Asset Utilization Ratio fell 38.76% year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (down 38.76% YoY) and the FY2024 annual result came in at 0.0, changed N/A from the prior year.
- Asset Utilization Ratio declined to 0.0 in Q2 2025, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 10.89 in Q3 2023 to a low of 0.0 in Q2 2025.
- A 3-year average of 3.96 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio tumbled 99.95% — and 2025, when it plunged 38.76%.
- Tracing NGNE's Asset Utilization Ratio over 3 years: stood at 6.41 in 2023, then slumped by 99.94% to 0.0 in 2024, then fell by 18.41% to 0.0 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2025), 0.0 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.00 |
| Dec 31, 2023 | 6.41 |
| Sep 30, 2023 | 10.89 |
| Jun 30, 2023 | 10.39 |
| Sep 30, 2019 | 14.28 |